You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Etoposide

Showing 51 - 75 of 1,852
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Medulloblastoma Trial in Beijing (Apatinib Combined With Temozolomide and Etoposide Capsules)

Recruiting
  • Recurrent Medulloblastoma
  • Apatinib Combined With Temozolomide and Etoposide Capsules
  • Beijing, China
    Beijing Sanbo Brain Hospital
Feb 10, 2022

Extensive-stage Small-cell Lung Cancer Trial in Hangzhou (QL1706, Carboplatin, Etoposide)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jul 13, 2022

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022

Lung Cancer Trial in United States (Osimertinib, Platinum, Etoposide)

Recruiting
  • Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jul 1, 2022

Classic Hodgkin's Lymphoma Trial in Beijing (Sintilimab, Carboplatin, Etoposide)

Recruiting
  • Classic Hodgkin's Lymphoma
  • Sintilimab
  • +4 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 12, 2022

Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Etoposide
  • +2 more
  • Hangzhou, Zhejiang, China
  • +6 more
Sep 7, 2022

Multiple Myeloma Trial in Seattle (Allopurinol, Carmustine, Etoposide)

Recruiting
  • Multiple Myeloma
  • Seattle, Washington
    Swedish Cancer Institute
Jun 21, 2022

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)

Completed
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Athens, Greece
  • +1 more
Sep 16, 2023

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 9, 2022

Osteosarcoma Trial in China, Korea, Republic of (Sulfatinib, Etoposide, Isophosphamide)

Not yet recruiting
  • Osteosarcoma
  • Beijing, Beijing, China
  • +4 more
Oct 19, 2022

SCLC, Extensive Stage Trial in Shanghai (AK112, Etoposide, Carboplatin)

Recruiting
  • SCLC, Extensive Stage
  • Shanghai, Shanghai, China
    Shun Lu
Oct 12, 2022

Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

Recruiting
  • Small Cell Lung Cancer
  • Lung Cancer
  • Aarau, Switzerland
  • +13 more
Aug 12, 2022

Small Cell Lung Cancer Trial in North Bethesda (ETOPOSIDE - Usual, ETOPOSIDE - Study)

Active, not recruiting
  • Small Cell Lung Cancer
  • ETOPOSIDE - Usual
  • ETOPOSIDE - Study
  • North Bethesda, Maryland
    Medicine Invention Design, Inc. (MIDI) - IORG0007849
Aug 30, 2021

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Relapsed Solid Tumors, Refractory Solid Tumors, Relapsed Leukemia Trial in Canada, United States (Carfilzomib, Cyclophosphamide,

Recruiting
  • Relapsed Solid Tumors
  • +3 more
  • Phoenix, Arizona
  • +7 more
Apr 12, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Lymphoma Trial in Duarte (drug, other, procedure)

Active, not recruiting
  • Lymphoma
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Effect of Drug, Drug, Toxicity Trial in Beijing (Apatinib+IE, IE)

Recruiting
  • Effect of Drug
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Mar 12, 2022

Merkel Cell Carcinoma Trial in Milan (Retifanlimab, Cisplatin, Etoposide)

Recruiting
  • Merkel Cell Carcinoma
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Jan 4, 2023

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

Recruiting
  • Small-cell Lung Cancer
  • New York, New York
    Columbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022

Lymphoma, Autologous Hematopoietic Stem Cell Transplantation Trial in Xi'an (Improved BEAM regimen)

Not yet recruiting
  • Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • Improved BEAM regimen
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022